Unilever’s Failed Bid Puts Pressure On GSK Spin-Out Plans

Bid Saw UK Pharma Major’s Shares Rise

 
• By Andrew McConaghie
  
GSK Skyline
GSK will now press ahead with its spin-out plan, unless another buyer emerges with a higher bid. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip